|
⚲
|
| Abbott Laboratories | |
|---|---|
| Ticker | ABT |
| CIK # | 0000001800 |
| CUSIP | 002824100 |
| Sector | Life Sciences |
| Industry | Pharmaceutical Preparations |
| Phone | 8479376100 |
| Address | 100 Abbott Park Road D-322 Ap6D Abbott Park, IL 60064-3500 |
| Source | [EDGAR] |
| Market Cap, 13F ($) |
|---|
| Business |
|---|
|
Abbott Laboratories is an Illinois corporation, incorporated in 1900. Abbott's* principal business is the discovery, development, manufacture, and sale of a broad and diversified line of health care products. Abbott has four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. On October 3, 2017, Abbott completed the acquisition of Alere Inc., a diagnostic device and service provider, for an aggregate consideration of approximately $4.5 billion in cash. |
| CIK | Filing | 2011 - 2023 |
|---|---|---|
| [0000001800] | 10-K | |
| [0000001800] | 10-Q | |
| [0000001800] | 3 | |
| [0000001800] | 4 | |
| [0000001800] | 8-K | |
| [0000001800] | SC 13D | |
| [0000001800] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| Capital Research Global Investors | Abbott Laboratories | [2019-02-14] | 6.9 |
| Abbott Laboratories | Aquabounty Technologies Inc | [2016-12-30] | 11.4 |
| Abbott Laboratories | Mylan NV | [2015-03-06] | 22.52 |
| Vanguard Group Inc | Abbott Laboratories | [2014-02-10] | 6.24 |
| [2013-02-08] | None | ||
| BlackRock Inc | Abbott Laboratories | [2012-02-09] | 5.32 |